{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:36:37Z","timestamp":1756384597514},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T00:00:00Z","timestamp":1340841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s11882-012-0268-1","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T18:20:30Z","timestamp":1340821230000},"page":"288-291","source":"Crossref","is-referenced-by-count":9,"title":["Biologic Agents in the Treatment of Urticaria"],"prefix":"10.1007","volume":"12","author":[{"given":"Allen P.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,28]]},"reference":[{"key":"268_CR1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-9343(70)80110-3","volume":"49","author":"D Houser","year":"1970","unstructured":"Houser D, Arbesman C, Ito K, et al. Cold urticaria. Immunologic studies. Am J Med. 1970;49:23\u201333.","journal-title":"Am J Med"},{"key":"268_CR2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0091-6749(75)90078-0","volume":"55","author":"A Kaplan","year":"1975","unstructured":"Kaplan A, Gray L, Shaff R, et al. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol. 1975;55:394\u2013402.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR3","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1056\/NEJM198110293051808","volume":"305","author":"A Kaplan","year":"1981","unstructured":"Kaplan A, Garofalo J, Sigler R, et al. Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Eng J Med. 1981;305:1074\u20137.","journal-title":"N Eng J Med"},{"key":"268_CR4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0002-9343(73)90221-0","volume":"54","author":"R Newcomb","year":"1973","unstructured":"Newcomb R, Nelson H. Dermographia mediated by immunoglobulin E. Am J Med. 1973;54:174\u201380.","journal-title":"Am J Med"},{"key":"268_CR5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jaci.2005.05.024","volume":"116","author":"A Fukunaga","year":"2005","unstructured":"Fukunaga A, Bito T, Tsuru K, et al. Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes. J Allergy Clin Immunol. 2005;116:397\u2013402.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jaci.2006.04.003","volume":"117","author":"J Boyce","year":"2006","unstructured":"Boyce J. Successful treatment of cold-induced urticaria\/anaphylaxis with anti-IgE. J Allergy Clin Immunol. 2006;117:1415\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1398-9995.2007.01591.x","volume":"63","author":"M Metz","year":"2008","unstructured":"Metz M, Bergmann P, Zuberbier T, et al. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy. 2008;63:247\u20139.","journal-title":"Allergy"},{"key":"268_CR8","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1398-9995.2008.01879.x","volume":"63","author":"O Guzelbey","year":"2008","unstructured":"Guzelbey O, Ardelean E, Magerl M, et al. Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy. 2008;63:1563\u20135.","journal-title":"Allergy"},{"key":"268_CR9","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1398-9995.2010.02409.x","volume":"65","author":"K Krause","year":"2010","unstructured":"\u2022 Krause K, Ardelean E, Kessler B, et al. Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy. Allergy. 2010;65:1494\u20135. Demonstrates that dermatographism that is refractory to high-dose antihistamine therapy may respond to anti-IgE therapy..","journal-title":"Allergy"},{"key":"268_CR10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1523-1747.ep12462239","volume":"90","author":"B Gruber","year":"1988","unstructured":"Gruber B, Baeza M, Marchese M, et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988;90:213\u20137.","journal-title":"J Invest Dermatol"},{"key":"268_CR11","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","volume":"328","author":"M Hide","year":"1993","unstructured":"Hide M, Francis D, Grattan C, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328:1599\u2013604.","journal-title":"N Engl J Med"},{"key":"268_CR12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaci.2007.05.008","volume":"120","author":"A Kaplan","year":"2007","unstructured":"Kaplan A, Joseph K. Basophil secretion in chronic urticaria: autoantibody-dependent or not? J Allergy Clin Immunol. 2007;120:729\u201330.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2222.2009.03256.x","volume":"39","author":"A Kaplan","year":"2009","unstructured":"Kaplan A, Greaves M. Pathogenesis of chronic urticaria. Clin Exp Allergy. 2009;39:777\u201387.","journal-title":"Clin Exp Allergy"},{"key":"268_CR14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaci.2004.12.1120","volume":"145","author":"S Soundararajan","year":"2005","unstructured":"Soundararajan S, Kikuchi Y, Joseph K, et al. Isolation of the pathogenic IgG subclasses in chronic autoimmune urticaria: Evidence that IgG1, IgG3, and IgG4 contain antireceptor antibodies that activate basophils while IgG2 is inactive. J Allergy Clin Immunol. 2005;145:815\u201321.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR15","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1067\/mai.2001.115484","volume":"107","author":"Y Kikuchi","year":"2001","unstructured":"Kikuchi Y, Kaplan A. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol. 2001;107:1056\u201362.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1067\/mai.2002.120954","volume":"109","author":"Y Kikuchi","year":"2002","unstructured":"Kikuchi Y, Kaplan A. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol. 2002;109:114\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0091-6749(86)90240-X","volume":"78","author":"J Elias","year":"1986","unstructured":"Elias J, Boss E, Kaplan A. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol. 1986;78:914\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0091-6749(99)70475-6","volume":"103","author":"R Sabroe","year":"1999","unstructured":"Sabroe R, Poon E, Orchard G, et al. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Allergy Clin Immunol. 1999;103:484\u201393.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","volume":"122","author":"A Kaplan","year":"2008","unstructured":"\u2022\u2022 Kaplan A, Joseph K, Maykut R, et al. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008;122:569\u201373. The first blinded, placebo-controlled demonstration that Omalizumab (IgG anti-IgE) can be used to treat difficult cases of chronic spontaneous urticaria with a likely autoimmune basis..","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaci.2011.06.010","volume":"128","author":"S Saini","year":"2011","unstructured":"Saini S, Rosen K, Hsieh H, et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011;128:567\u201373. A Phase II study of Omalizumab therapy of chronic spontaneous urticaria without regard to the presence or absence of autoimmune manifestations..","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60644-8","volume":"99","author":"S Spector","year":"2007","unstructured":"Spector S, Tan R. Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol. 2007;99:190\u20133.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"268_CR22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1398-9995.2010.02472.x","volume":"66","author":"A Groffik","year":"2011","unstructured":"Groffik A, Mitzel-Kaoukhov H, Magerl M, et al. Omalizumab\u2013an effective and safe treatment of therapy-resistant chronic spontaneous urticaria. Allergy. 2011;66:303\u20135.","journal-title":"Allergy"},{"key":"268_CR23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S1081-1206(10)60069-5","volume":"100","author":"D Dreyfus","year":"2008","unstructured":"Dreyfus D. Observations on the mechanism of omalizumab as a steroid-sparing agent in autoimmune or chronic idiopathic urticaria and angioedema. Ann Allergy Asthma Immunol. 2008;100:624\u20135.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"268_CR24","first-page":"252","volume":"20","author":"E Iemoli","year":"2010","unstructured":"Iemoli E, Piconi S, Fusi A, et al. Immunological effects of omalizumab in chronic urticaria: a case report. J Investig Allergol Clin Immunol. 2010;20:252\u20134.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"268_CR25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.anai.2009.11.017","volume":"104","author":"C Romano","year":"2010","unstructured":"Romano C, Sellitto A, De Fanis U, et al. Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria. Ann Allergy Asthma Immunol. 2010;104:95\u20137.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"268_CR26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jaci.2011.04.038","volume":"128","author":"M Maurer","year":"2011","unstructured":"Maurer M, Altrichter S, Bieber T, et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol. 2011;128:202\u20139. A confirmatory large placebo-controlled study of the use of Omalizumab in patients with chronic spontaneous urticaria, focused on the presence of IgE antithyroid antibodies..","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR27","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jaci.2010.12.1085","volume":"127","author":"M Ferrer","year":"2011","unstructured":"Ferrer M, Gamboa P, Sanz M, et al. Omalizumab is effective in non-autoimmune urticaria. J Allergy Clin Immunol. 2011;127:1300\u20132.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaci.2007.07.041","volume":"120","author":"M Sands","year":"2007","unstructured":"Sands M, Blume J, Schwartz S. Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. J Allergy Clin Immunol. 2007;120:979\u201381.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaci.2008.11.043","volume":"123","author":"P Arkwright","year":"2009","unstructured":"Arkwright P. Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria. J Allergy Clin Immunol. 2009;123:510\u20131.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1067\/mai.2001.118790","volume":"108","author":"H Hoffman","year":"2001","unstructured":"Hoffman H, Wanderer A, Broide D. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol. 2001;108:615\u201320.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR31","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2009.11.001","volume":"124","author":"H Hoffman","year":"2009","unstructured":"Hoffman H. Therapy of autoinflammatory syndromes. J Allergy Clin Immunol. 2009;124:1129\u201338.","journal-title":"J Allergy Clin Immunol"},{"key":"268_CR32","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","volume":"58","author":"H Hoffman","year":"2008","unstructured":"Hoffman H, Throne M, Amar N, et al. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum. 2008;58:2443\u201352.","journal-title":"Arthritis Rheum"},{"key":"268_CR33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1081-1206(10)60064-6","volume":"100","author":"P Frischmeyer-Guerrerio","year":"2008","unstructured":"Frischmeyer-Guerrerio P, Rachamalla R, Saini S. Remission of Schnitzler syndrome after treatment with anakinra. Ann Allergy Asthma Immunol. 2008;100:617\u20139.","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-012-0268-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-012-0268-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-012-0268-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:42:28Z","timestamp":1559432548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-012-0268-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,28]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["268"],"URL":"https:\/\/doi.org\/10.1007\/s11882-012-0268-1","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,28]]}}}